Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Study Number: 

NCG 280715

Phase: 
2/3
Trial categories: 
Glioblastoma
Brain Cancer
Principal Investigator: